Drug Trial Radar · NCT02686138
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
Last checked: Nov 19, 2026Latest source record: Apr 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
593
Actual
Start
Dec 2015
Primary completion
Aug 2017
Study completion Oct 2017
Sponsor
- Lead sponsor
- ArdelyxIndustry
- Sponsor type
- Industry
- First posted
- Feb 19, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase 3, 26-week, randomized, double-blind, placebo-controlled, multi-center study will evaluate the safety and efficacy of one dose of Tenapanor in subjects with constipation-predominant irritable bowel syndrome (IBS-C) as defined by the ROME III criteria and who have active disease as determined after a two-week screening period. Subjects who qualify and are randomized into the study will either receive 50mg BID of Tenapanor (1:1) for a 26 week treatment period.
Conditions
- Constipation Predominant Irritable Bowel Syndrome
Interventions
TenapanorDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With Overall Response for 6 Out of 12 WeeksTime frame: First 12 weeks
Locations
117 sites in 1 country. Site status is shown where the registry gives one.
Ardelyx Investigative Site 257
Dothan, Alabama
Ardelyx Investigative Site 200
Foley, Alabama
Ardelyx Investigative Site 103
Huntsville, Alabama
Ardelyx Investigative Site 244
Huntsville, Alabama
Ardelyx Investigative Site 251
Huntsville, Alabama
Ardelyx Investigative Site 100
Huntsville, Alabama
Ardelyx Investigative Site 209
Saraland, Alabama
Ardelyx Investigative Site 210
Phoenix, Arizona
Ardelyx Investigative Site 296
Phoenix, Arizona
Ardelyx Investigative Site 269
Tucson, Arizona
Ardelyx Investigative Site 256
Tucson, Arizona
Ardelyx Investigative Site 292
Conway, Arkansas
Ardelyx Investigative Site 122
Little Rock, Arkansas
Ardelyx Investigative Site 163
Anaheim, California
Ardelyx Investigative Site 105
Canoga Park, California
Ardelyx Investigative Site 143
Chula Vista, California
Ardelyx Investigative Site 147
Encino, California
Ardelyx Investigative Site 297
La Mesa, California
Ardelyx Investigative Site 284
La Mirada, California
Ardelyx Investigative Site 107
Lomita, California
Ardelyx Investigative Site 165
Long Beach, California
Ardelyx Investigative Site 211
Orange, California
Ardelyx Investigative Site 233
Wheat Ridge, Colorado
Ardelyx Investigative Site 212
Bristol, Connecticut
Ardelyx Investigative Site 176
Brandon, Florida
Ardelyx Investigative Site 178
Cutler Bay, Florida
Ardelyx Investigative Site 136
Hialeah, Florida
Ardelyx Investigative Site 130
Hialeah, Florida
Ardelyx Investigative Site 191
Lynn Haven, Florida
Ardelyx Investigative Site 288
Miami, Florida
Ardelyx Investigative Site 106
Miami, Florida
Ardelyx Investigative Site 127
Miami Lakes, Florida
Ardelyx Investigative Site 179
Orlando, Florida
Ardelyx Investigative Site 290
Tampa, Florida
Ardelyx Investigative Site 254
West Palm Beach, Florida
Ardelyx Investigative Site 138
Atlanta, Georgia
Ardelyx Investigative Site 148
Atlanta, Georgia
Ardelyx Investigative Site 253
Atlanta, Georgia
Ardelyx Investigative Site 272
Decatur, Georgia
Ardelyx Investigative Site 229
Decatur, Georgia
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.